MAPT and Alzheimer disease: We next ran the cytosolic and synaptic fractions from all cases across all regions on the tau seeding assay to measure the amount of tau seeding activity in the cytosol and synapses along the Braak Tau Pathway in both early and late AD conditions (Figure 5D).